|
2024
|
Invention
|
Ophthalmic composition.
Provided herein is an ophthalmic composition. In some embodiments, the o... |
|
|
P/S
|
Pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; pharma... |
|
|
P/S
|
Pharmaceutical preparations and substances for the prevention and treatment of eye disorders, con... |
|
2023
|
Invention
|
Ophthalmic composition and delivery device thereof.
Provided herein is an ophthalmic composition... |
|
|
P/S
|
pharmaceutical preparations and substances for the prevention and treatment of eye disorders, con... |
|
2022
|
Invention
|
Ophthalmic composition. Provided herein is an ophthalmic composition. In some embodiments, the op... |
|
|
Invention
|
Ophthalmic compositions for presbyopia.
Provided herein is an ophthalmic composition. In some em... |
|
|
Invention
|
Ophthalmic compositions for presbyopia. Provided herein is an ophthalmic composition. In some emb... |
|
2021
|
Invention
|
2o stabilized pharmaceutical formulations. Provided herein is an ophthalmic composition formulate... |
|
2020
|
Invention
|
Ophthalmic compositions comprising d2o.
Provided herein is an ophthalmic composition. In some em... |
|
|
Invention
|
Ophthalmic compositions comprising d2o. Provided herein is an ophthalmic composition. In some emb... |
|
|
Invention
|
D2o stabilized pharmaceutical formulations. Provided herein is an ophthalmic composition formulat... |
|
2018
|
Invention
|
Ophthalmic composition and delivery device thereof. Provided herein is an ophthalmic composition.... |
|
|
P/S
|
Eyedrops for the treatment of myopia in children. |
|
2015
|
Invention
|
Ophthalmic composition comprising atropine or atropine sulphate. Provided herein is an ophthalmic... |
